CIBC analyst Paul Holden downgraded Scotiabank (BNS) to Neutral from Outperformer with a price target of C$81, down from C$84. While still ...
In a report released today, Greg Harrison from Scotiabank maintained a Buy rating on Agios Pharma (AGIO – Research Report), with a price target ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback